Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111132783> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W3111132783 abstract "Abstract Developing new therapies for patients with glioblastoma (GBM) requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by over 130 global key opinion leaders in consultation with health authorities to provide an optimal mechanism for phase 2/3 development in GBM. The Sponsor of GBM AGILE is the Global Coalition for Adaptive Research, whose mission is to accelerate the development of treatments rare and deadly diseases by serving as sponsor of innovative trials. GBM AGILE is an international platform trial designed to evaluate multiple therapies in newly diagnosed and recurrent GBM. Its goals are to identify effective therapies for GBM and match effective therapies with patient subtypes, with data generated to support regulatory filing for new drug applications. Bayesian response adaptive randomization is used within subtypes of the disease to assign participants to investigational arms based on their performance. The primary endpoint is overall survival. The trial is being conducted under a master Investigational New Drug Application/Clinical Trial Agreement and Master Protocol, allowing multiple drugs from different companies to be evaluated simultaneously and/or over time. The plan is to add experimental therapies as new information is identified and remove therapies as they complete their individual evaluation against a common control. GBM AGILE received IND approval from the FDA in April 2019, screening its first patient in June 2019. As of June 2020 over 200 patients have been screened. Expansion to Canada, Europe, China, and Australia is also underway. There is currently one investigational arm under evaluation in the trial, with two additional arms to be added in Q4 2020/ Q1 2021. Clinical trial information: NCT03970447." @default.
- W3111132783 created "2020-12-21" @default.
- W3111132783 creator A5000656122 @default.
- W3111132783 creator A5004781307 @default.
- W3111132783 creator A5006268625 @default.
- W3111132783 creator A5011340023 @default.
- W3111132783 creator A5012241694 @default.
- W3111132783 creator A5017177249 @default.
- W3111132783 creator A5020324479 @default.
- W3111132783 creator A5021656597 @default.
- W3111132783 creator A5025351354 @default.
- W3111132783 creator A5035464154 @default.
- W3111132783 creator A5047608444 @default.
- W3111132783 creator A5047888321 @default.
- W3111132783 creator A5050790844 @default.
- W3111132783 creator A5051494466 @default.
- W3111132783 creator A5054809773 @default.
- W3111132783 creator A5055183757 @default.
- W3111132783 creator A5057541817 @default.
- W3111132783 creator A5063511816 @default.
- W3111132783 creator A5072507966 @default.
- W3111132783 creator A5073571977 @default.
- W3111132783 creator A5088670473 @default.
- W3111132783 date "2020-11-01" @default.
- W3111132783 modified "2023-10-16" @default.
- W3111132783 title "RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA" @default.
- W3111132783 doi "https://doi.org/10.1093/neuonc/noaa215.816" @default.
- W3111132783 hasPublicationYear "2020" @default.
- W3111132783 type Work @default.
- W3111132783 sameAs 3111132783 @default.
- W3111132783 citedByCount "0" @default.
- W3111132783 crossrefType "journal-article" @default.
- W3111132783 hasAuthorship W3111132783A5000656122 @default.
- W3111132783 hasAuthorship W3111132783A5004781307 @default.
- W3111132783 hasAuthorship W3111132783A5006268625 @default.
- W3111132783 hasAuthorship W3111132783A5011340023 @default.
- W3111132783 hasAuthorship W3111132783A5012241694 @default.
- W3111132783 hasAuthorship W3111132783A5017177249 @default.
- W3111132783 hasAuthorship W3111132783A5020324479 @default.
- W3111132783 hasAuthorship W3111132783A5021656597 @default.
- W3111132783 hasAuthorship W3111132783A5025351354 @default.
- W3111132783 hasAuthorship W3111132783A5035464154 @default.
- W3111132783 hasAuthorship W3111132783A5047608444 @default.
- W3111132783 hasAuthorship W3111132783A5047888321 @default.
- W3111132783 hasAuthorship W3111132783A5050790844 @default.
- W3111132783 hasAuthorship W3111132783A5051494466 @default.
- W3111132783 hasAuthorship W3111132783A5054809773 @default.
- W3111132783 hasAuthorship W3111132783A5055183757 @default.
- W3111132783 hasAuthorship W3111132783A5057541817 @default.
- W3111132783 hasAuthorship W3111132783A5063511816 @default.
- W3111132783 hasAuthorship W3111132783A5072507966 @default.
- W3111132783 hasAuthorship W3111132783A5073571977 @default.
- W3111132783 hasAuthorship W3111132783A5088670473 @default.
- W3111132783 hasBestOaLocation W31111327831 @default.
- W3111132783 hasConcept C115903868 @default.
- W3111132783 hasConcept C126322002 @default.
- W3111132783 hasConcept C14185376 @default.
- W3111132783 hasConcept C143998085 @default.
- W3111132783 hasConcept C19527891 @default.
- W3111132783 hasConcept C203092338 @default.
- W3111132783 hasConcept C2776194525 @default.
- W3111132783 hasConcept C41008148 @default.
- W3111132783 hasConcept C502942594 @default.
- W3111132783 hasConcept C535046627 @default.
- W3111132783 hasConcept C71924100 @default.
- W3111132783 hasConceptScore W3111132783C115903868 @default.
- W3111132783 hasConceptScore W3111132783C126322002 @default.
- W3111132783 hasConceptScore W3111132783C14185376 @default.
- W3111132783 hasConceptScore W3111132783C143998085 @default.
- W3111132783 hasConceptScore W3111132783C19527891 @default.
- W3111132783 hasConceptScore W3111132783C203092338 @default.
- W3111132783 hasConceptScore W3111132783C2776194525 @default.
- W3111132783 hasConceptScore W3111132783C41008148 @default.
- W3111132783 hasConceptScore W3111132783C502942594 @default.
- W3111132783 hasConceptScore W3111132783C535046627 @default.
- W3111132783 hasConceptScore W3111132783C71924100 @default.
- W3111132783 hasLocation W31111327831 @default.
- W3111132783 hasLocation W31111327832 @default.
- W3111132783 hasLocation W31111327833 @default.
- W3111132783 hasOpenAccess W3111132783 @default.
- W3111132783 hasPrimaryLocation W31111327831 @default.
- W3111132783 hasRelatedWork W2422317 @default.
- W3111132783 hasRelatedWork W2544042 @default.
- W3111132783 hasRelatedWork W3582852 @default.
- W3111132783 hasRelatedWork W3878688 @default.
- W3111132783 hasRelatedWork W3918396 @default.
- W3111132783 hasRelatedWork W518170 @default.
- W3111132783 hasRelatedWork W585099 @default.
- W3111132783 hasRelatedWork W6821303 @default.
- W3111132783 hasRelatedWork W1676928 @default.
- W3111132783 hasRelatedWork W4007547 @default.
- W3111132783 isParatext "false" @default.
- W3111132783 isRetracted "false" @default.
- W3111132783 magId "3111132783" @default.
- W3111132783 workType "article" @default.